SureTrader SureTrader
Home > Boards > US Listed > Medical - Drugs >

NovaBay Pharmaceuticals, Inc. (NBY)

NBY RSS Feed
Add NBY Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 8/16/2016 12:07:01 AM - Followers: 41 - Board type: Free - Posts Today: 0





 

Corporate Profile
 

ANTI-INFECTIVE COMPOUNDS EFFECTIVE AGAINST BACTERIA, VIRUSES AND FUNGI

NovaBay Pharmaceuticals is a clinical-stage biotechnology company focused on developing its proprietary and patented Aganocide® compounds. Aganocides are novel, broad-spectrum, fast-acting, synthetic anti-infectives designed to mimic the body's defense against infection. They are active against bacteria, fungi and viruses, and are being developed to treat and prevent a wide range of local, non-systemic infections with a low likelihood of developing bacterial resistance.

NOVABAY'S FOUR BUSINESS UNITS

NovaBay is focusing its technology on four distinct therapeutic areas: dermatology, ophthalmology, urology and hospital infections. In dermatology, the focus is on developing NVC-422 gel for impetigo and acne. NovaBay has the advantage of being partnered with Galderma, the leading dermatology company in the world. In ophthalmology, the company anticipates continuing its development of NVC-422 for the treatment of adenoviral conjunctivitis to confirm the encouraging results shown for epidemic keratoconjunctivitis (EKC) seen in the adenoviral conjunctivitis trial. In urology, NovaBay aims to reduce the incidence of urinary catheter blockage and encrustation (UCBE) and the associated urinary tract infections with an irrigation solution containing NVC-422. In hospital infection, NovaBay is targeting the six-million-patient market of chronic non-healing wounds, such as pressure, venous stasis and diabetic ulcers with its proprietary wound cleansing solution containing pure hypochlourus acid solution, NeutroPhase®, which has received two 510(k) clearances from the Food and Drug Administration.

COLLABORATION WITH GALDERMA

NovaBay has entered into and recently expanded an agreement with Galderma S.A. to develop and commercialize Aganocide compounds in acne, impetigo and other dermatological indications.


 

Investor Overview
 

NovaBay Pharmaceuticals is a clinical stage biotechnology company focused on developing its proprietary and patented topical Aganocide® compounds, which are novel, synthetic anti-infective product candidates with equivalent activity to the active antimicrobial molecules generated within white blood cells. NovaBay's topical Aganocide compounds are being developed to treat and prevent a wide range of infections without causing bacterial resistance. NovaBay has internal development programs aimed at addressing hospital infections, chronic non-healing wounds, UCBE and onychomycosis.

NovaBay has entered into and recently expanded an agreement with Galderma S.A. to develop and commercialize Aganocide compounds in acne, impetigo and other dermatological indications.


 

Transfer Agent
 

The transfer agent and registrar for our common stock is Computershare Trust Company, N.A. with the following contact information:

For standard US postal mail
Computershare Trust Company, N.A.
Po Box 43070
Providence, RI 02940-3070

For overnight/express delivery
Computershare Trust Company, N.A.
250 Royall Street
Canton, MA 02021

For DWAC instructions provided to brokers
FAST Transfer Agent number - 50173

Telephone and Fax
Toll free in the US +1 800 962 4284
Telephone +1 303-262-0600
Fax +1 303-262-0700


Website
www.computershare.com

eMail inquiries
web.queries@computershare.com

Investor Relations contacts
Theresa Granados
(510) 899-8870
Email Theresa


 

Regulatory Filings - http://www.novabaypharma.com/investors/filings

Share Structure

Market Value- $38,748,193 a/o - Apr 04, 2012

Shares Outstanding - 28,916,562 a/o - Mar 16, 2012

 

2012 Outside News Sources
Publish Date - Headline

Apr 5, 2012 NovaBay Pharmaceuticals Launches CEO Blog
Mar 20, 2012 NovaBay Pharmaceuticals Signs Option Agreement with Virbac Animal Health for Aganocide(R) Compounds
Mar 20, 2012 NovaBay Set for " Phenomenal Year" With Key Upcoming Clinical Data Announcements and Partnership Developments
Mar 6, 2012 NovaBay Pharmaceuticals to Present at Two Upcoming Investor Conferences in March
Feb 29, 2012 NovaBay Issues Statement Regarding Market Activity
Feb 8, 2012 NovaBay Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference
Feb 7, 2012 NovaBay Pharmaceuticals to Hold Conference Call to Provide Year-End Business Update and 2012 Outlook
Jan 23, 2012 NovaBay Prepares to Launch Global Phase 2b Ophthalmic Study of NVC-422
Jan 9, 2012 NovaBay Pharmaceuticals Announces Strategic Marketing Agreement for NeutroPhase in China


 

SEC Transaction Summary - Last 6 Months
 

Buy/Sell
Buys 2 - Sells 0 - Total 2
Shares Bought 90,000 - Sold 0 - Gross 90,000 - Net 90,000





 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NBY
Current Price
Volume:
Bid Ask Day's Range
SureTrader
NBY News: Statement of Changes in Beneficial Ownership (4) 09/26/2016 06:15:15 PM
NBY News: Statement of Changes in Beneficial Ownership (4) 09/26/2016 06:06:13 PM
NBY News: Statement of Changes in Beneficial Ownership (4) 09/26/2016 05:46:31 PM
NBY News: NovaBay Pharmaceuticals’ Auriclosene® Demonstrates Statistically Significant & Clinically Meaningful Results in Phase 2b S... 09/19/2016 06:50:00 AM
NBY News: Statement of Beneficial Ownership (sc 13d) 09/16/2016 04:32:16 PM
PostSubject
#271   This biotech is on fire..see you at $19+ biotechnician 08/16/16 12:07:01 AM
#270   Sold all shares at 5.00. Tkrtape 08/15/16 11:47:41 AM
#269   Becoming the best ANTI-INFECTIVE COMPOUNDS EFFECTIVE AGAINST BACTERIA, biotechnician 08/14/16 08:52:53 AM
#268   $4.69 wow ClearlyStocks 08/12/16 05:54:49 PM
#267   * * $NBY Video Chart 08-12-16 * * ClayTrader 08/12/16 04:54:50 PM
#266   Wow. In $3.90 and now $4.55 ClearlyStocks 08/12/16 04:23:55 PM
#265   Nice day today will it keep a rolling? Kcricket 08/12/16 04:17:35 PM
#264   This message board better wake up! Someone on the Tkrtape 04/29/16 03:18:29 PM
#263   http://www.barrons.com/articles/SB52339111409336214409504581647252423611280 Bew Tkrtape 04/07/16 11:11:15 PM
#262   durn, i miss stated what I meant to Monroe1 12/31/15 10:49:28 AM
#261   no they reduce shares and raise the price...F/S Roy London 12/31/15 08:56:20 AM
#260   Roy, as a rule don't most reverse splits Monroe1 12/31/15 08:11:45 AM
#259   NBY weeeeeeeeeeeeee Roy London 12/21/15 09:38:01 AM
#258   NBY in for the post split pop Roy London 12/21/15 09:27:33 AM
#257   Must be a nobody stock open 3 years LongPluto 12/03/15 08:16:07 PM
#256   .185 X .20 now on watch M-invest 11/02/15 10:08:10 AM
#255   On watch. 50% discount. GMONEY4 10/23/15 03:57:12 PM
#254   New public offering... Stay away.. db 10/23/15 10:43:14 AM
#253   What's new here? tmeier 10/23/15 10:41:07 AM
#252   *NovaBay Pharma Sees Q3 Avenova Sales Topping $1M, db 10/08/15 10:24:47 AM
#251   NovaBay Pharmaceuticals To Sell Eye Product Through Lenscrafters 9/16/15, db 09/16/15 03:52:29 PM
#250   NBY gonna get jiggly soon... .3999 now db 09/03/15 11:34:12 AM
#249   These guys knew the stock price would sink. Tkrtape 08/20/15 08:16:15 PM
#248   Down large on small volume. willlbone 08/20/15 10:46:01 AM
#247   Agree. Minding 08/14/15 09:30:48 AM
#246   It was a nice increase in sales, Tkrtape 08/13/15 08:36:44 PM
#245   ... and the CC is at http://novabay.com/investors/events Minding 08/13/15 03:04:00 PM
#244   2nd Q ER after close 8/13/15 db 08/13/15 02:21:05 PM
#243   I hope good news is coming. serious38 08/06/15 01:26:32 PM
#242   NovaBay Pharmaceuticals Sees Large Drop in Short Interest db 08/02/15 10:47:04 PM
#241   Some things to keep in mind- Tkrtape 07/31/15 01:11:43 PM
#240   That is very possible I feel... I have db 07/30/15 03:04:10 PM
#239   Picked up 5,000 today, adding to my position. DavenCT 07/30/15 12:44:10 PM
#238   Thanks for sharing db 07/30/15 11:27:30 AM
#237   DavenCT, thanks for the boot-on-the-ground report. Minding 07/30/15 11:07:16 AM
#236   Hi folks, I'm new to this board.... DavenCT 07/29/15 09:21:05 PM
#235   Nope!! :) well let's see what Monday morning brings. db 07/26/15 10:11:40 PM
#234   NBY down -6%.... at .60cents. My feeling db 07/24/15 11:39:13 AM
#233   interesting late day trading....low volume and new high db 07/23/15 04:28:24 PM
#232   NBY is going back to $1.00. Sellers have serious38 07/08/15 10:44:26 AM
#231   Has anyone seen any news to warrant the Minding 07/07/15 10:05:10 AM
#230   Another ... http://ih.advfn.com/p.php?pid=nmona&article=67312343&xref=newsalert Minding 06/17/15 08:11:24 AM
#229   NovaBay Pharmaceuticals, Inc. Analyst Rating Update Minding 06/11/15 08:28:48 AM
#228   FDA Clears NovaBay Pharmaceuticals’ New High-Tech Device, intelli-Case, Minding 06/04/15 09:39:07 AM
#227   Seems like a reasonable conclusion. Minding 05/22/15 12:11:10 PM
#226   This company is burning cash at $5 million Tkrtape 05/22/15 11:05:00 AM
#225   That perhaps explain the last minute pop yesterday. Minding 05/22/15 08:43:15 AM
#224   Promising company here.... My friend who has been db 05/22/15 08:36:50 AM
#223   These guys could easily do these dilutive offerings Tkrtape 05/22/15 08:27:48 AM
#222   NovaBay Announces $6.86M "At Market" Private Placement 5/22/15, 7:02 db 05/22/15 08:13:01 AM
PostSubject